Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NeoStem, Inc. (NBS)

(MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NBS
DateTimeSourceHeadlineSymbolCompany
28/07/201513:20Dow Jones NewsDiageo Terminates Heineken Partnership in South AfricaLSE:NBSNamibia Breweries Ltd.
08/06/201521:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NBS(MM)
08/06/201521:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NBS(MM)
05/06/201521:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NBS(MM)
29/05/201513:26GlobeNewswire Inc.NeoStem Announces Plans to Change Name to Caladrius Biosciences Reflecting Transformation Into Immunotherapy CompanyNASDAQ:NBS(MM)
29/05/201511:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NBS(MM)
28/05/201522:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:NBS(MM)
27/05/201523:53GlobeNewswire Inc.NeoStem Prices $25,000,000 Public Offering of Common StockNASDAQ:NBS(MM)
27/05/201522:17Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:NBS(MM)
27/05/201522:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NBS(MM)
27/05/201521:01GlobeNewswire Inc.NeoStem Announces Proposed Public Offering of Common StockNASDAQ:NBS(MM)
26/05/201512:30GlobeNewswire Inc.NeoStem Announces Dr. Merrick Ross of MD Anderson Cancer Center as Lead Principal Investigator for Pivotal Phase 3 Trial for ...NASDAQ:NBS(MM)
21/05/201520:03GlobeNewswire Inc.Turning Cancer Against Itself: Major Grant Advances Pioneering Melanoma Therapy at NeoStemNASDAQ:NBS(MM)
06/05/201511:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NBS(MM)
06/05/201511:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NBS(MM)
05/05/201512:30GlobeNewswire Inc.NeoStem, Inc. Announces 2015 First Quarter Financial Results and Provides Corporate UpdateNASDAQ:NBS(MM)
04/05/201512:30GlobeNewswire Inc.NeoStem to Present at Multiple May and June ConferencesNASDAQ:NBS(MM)
29/04/201521:01GlobeNewswire Inc.NeoStem Announces First Patient Randomized in Pivotal Phase 3 Melanoma Immunotherapy Clinical TrialNASDAQ:NBS(MM)
29/04/201513:30PR Newswire (US)Cryoport Supports NeoStem's Intus Study for the Treatment of Metastatic MelanomaNASDAQ:NBS(MM)
27/04/201512:30GlobeNewswire Inc.NeoStem's Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From the European Medicines AgencyNASDAQ:NBS(MM)
20/04/201512:30GlobeNewswire Inc.NeoStem Announces Expanded Cell Therapy Manufacturing Relationship With Kite PharmaNASDAQ:NBS(MM)
09/04/201512:30GlobeNewswire Inc.NeoStem Announces Extension of Study Under Grant From California Institute of Regenerative Medicine (CIRM) to Fund Research o...NASDAQ:NBS(MM)
06/04/201512:30GlobeNewswire Inc.NeoStem to Present at Multiple April ConferencesNASDAQ:NBS(MM)
16/03/201510:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NBS(MM)
16/03/201510:00GlobeNewswire Inc.NeoStem Announces PreSERVE AMI Clinical Trial One-Year Follow-Up ResultsNASDAQ:NBS(MM)
12/03/201511:30GlobeNewswire Inc.NeoStem to Present at Two Upcoming Investor Conferences in MarchNASDAQ:NBS(MM)
05/03/201512:30GlobeNewswire Inc.NeoStem PreSERVE AMI Clinical Trial One-Year Results to be Presented at American College of Cardiology Annual Scientific Sess...NASDAQ:NBS(MM)
02/03/201521:01GlobeNewswire Inc.NeoStem, Inc. Announces 2014 Year-End Financial Results and Provides Corporate UpdateNASDAQ:NBS(MM)
22/01/201522:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NBS(MM)
16/01/201521:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NBS(MM)
 Showing the most relevant articles for your search:NASDAQ:NBS